Pharma backing more than 200 developing-world health programmes
This article was originally published in Scrip
Executive Summary
More than 200 long-term health programmes designed to benefit the developing world are being supported by the pharmaceutical industry, a new report by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has revealed.